Weight loss drugs may improve job prospects and dating odds for one group

Twenty-nine percent is not a rounding error. When a study finds that people's dating and marriage prospects jump that much after roughly a year and a half on weight loss drugs, that tells you something less about pharmacology and more about how brutally shallow the mating and hiring markets already were before the drug showed up. The medicine didn't invent bias against overweight people. It just gave a workaround to those who could afford it.

That's the part of this story worth sitting with. We're constantly told that judging people by their bodies is shallow and cruel, and mostly it is. But markets don't grade on a curve for good intentions. Employers, landlords, dates, they were already sorting people by appearance long before Ozempic showed up on the scene, and no amount of scolding changed that. What changed the outcome was a drug, not a lecture.

There's a real cost angle here too, and it's not a small one. These drugs run hundreds of dollars a month without insurance, and plenty of insurers still balk at covering them for anything short of diabetes. So if losing weight genuinely opens doors at work and in relationships, we've created another sorting mechanism where the people who can pay get the upgrade and everyone else doesn't. That's not a reason to ban the drugs. It's a reason to be honest about what kind of society keeps producing problems that only cash can fix.

None of this requires hand-wringing about vanity or self-esteem. People want better jobs and better relationships, and if a medication helps them get there, good for them. The uncomfortable question isn't whether they should take it. It's why the door was ever closed so tightly in the first place.